Maegawa, Y., Kato, T., Fukuhara, S., Kiuchi, H., Imamura, R., Uemura, M., . . . Fujita, K. (2020). Resumption of anti‐programmed cell death 1 monotherapy for severe immune‐related adverse events experienced patient with renal cell carcinoma. IJU Case Rep.

Maegawa, Yoko, Taigo Kato, Shinichiro Fukuhara, Hiroshi Kiuchi, Ryoichi Imamura, Motohide Uemura, Norio Nonomura, ja Kazutoshi Fujita. "Resumption of Anti‐programmed Cell Death 1 Monotherapy for Severe Immune‐related Adverse Events Experienced Patient With Renal Cell Carcinoma." IJU Case Rep 2020.

Maegawa, Yoko, et al. "Resumption of Anti‐programmed Cell Death 1 Monotherapy for Severe Immune‐related Adverse Events Experienced Patient With Renal Cell Carcinoma." IJU Case Rep 2020.